In 1997, the FDA opened the flood gates on direct-to-consumer advertising, thus allowing drugmakers to promote their products on television. DTC has raised awareness of disease and prompted consumers to talk to their doctor about often sensitive topics, but it has also aroused some controversy.

In a recent editorial, Ian Spatz, a former vice president for global health policy at Merck, says doctors feel pressured to prescribe the drugs patients request. And critics say the ads push consumer to ask their doctors for expensive branded drugs, driving up the cost of healthcare.

He suggests drugmakers collaborate on disease-focused campaigns that raise awareness of certain conditions and urge patients to talk to their doctors for treatment options. Doing so would cut companies' advertising budgets, end the ridiculous laundry list of frightening side effects mandated by the FDA, and deliver important information to patients.

While TV proved the dominant medium for DTC in the early 2000s, things might be changing, as Gregory Aston pointed out recently in a blog post for Marketing: Health. In 2010, TV investment fell 17 percent, more than twice the rate of the total category. GSK and six other major pharmaceutical companies significantly reduced their TV investment. Meanwhile, there was a growth seen print (plus 13 percent in 2010, Aston points out). He doesn't see this as a surprise, as it is a tried and tested method to getting the industry's point across.


DTC advertising

Latest Headlines

Latest Headlines

Time for broader study of DTC's effectiveness

The hubbub over this week's DTC advertising study would be more convincing if it had looked at more drugs than just one, writes Jim Edwards at BNet Pharma. The Archives of Internal Medicine published

Study: Plavix ads boosted prices, not sales

Does pharma's consumer advertising increase sales--or just prices? A new study in the Archives of Internal Medicine found that at least for Plavix, the blockbuster blood thinner marketed by

A feast of food for thought on social media

Last week's two-day hearing on online drug marketing and social media was definitely a marathon, both in time logged and words entered into the record. Ideas flew from online providers and drugmakers

Is it time to back off DTC advertising?

In the annals of DTC advertising, this is the Irony edition. Instead of asking their doctors for branded meds by name, patients are mentioning a type of drug, but not the brand. Not exactly a

The TV ad that changed the drug world

Anyone remember when pharma marketing was limited to doctor-oriented pitches? NPR takes us back to that time, highlighting the brainstorm of Joe Davis, who figured out in 1986 how to advertise the

Franken backs repeal of DTC tax break

There's another lawmaker eyeing the tax deduction for drug advertising: Sen. Al Franken has introduced a bill ending that tax provision, saying that drugmakers should be focusing on development, not

PhRMA ads to back Baucus reform plan

The Senate healthcare plan championed by Sen. Max Baucus is about to get a boost from pharma. The industry trade group PhRMA is prepping a series of TV ads that specifically support Baucus's version

Lawmakers take aim at DTC ads

While pharma tunes up its advertising in support of healthcare reform, lawmakers are considering a little ad reform of their own. Yep, it's DTC regulation time, with Congressional reps eyeing

Pharma mulls $100M reform-ad campaign

You've heard that drugmakers have funded a new Harry-and-Louise ad campaign for healthcare reform. You may have even seen some of the commercials. Well, get ready for lots more pharma-backed

Marketing experts start shaping a message in Phase II

Once upon a time drug developers would wait until they had solid Phase III data and an NDA filed before they would think about the marketing campaign needed to sell the drug. These days, the experts